Loading...

Allergy Therapeutics plc

AGY.L•LSE
Healthcare
Drug Manufacturers - Specialty & Generic
£8.50
£0.50(6.25%)

Allergy Therapeutics plc (AGY.L) Stock Chart & Performance Analysis

Explore Allergy Therapeutics plc’s stock chart, historical data, and performance trends for a deeper market understanding.

1-Day Change
-4.35%
5-Day Change
-14.06%
1-Month Change
-15.38%
3-Month Change
-25.27%
6-Month Change
29.41%
Year-to-Date (YTD) Change
-19.12%
1-Year Change
92.98%
3-Year Change
-99.77%
5-Year Change
-99.50%
All-Time (Max) Change
274.15%

Analyzing Allergy Therapeutics plc (AGY.L) Trends Across Multiple Time Frames

Allergy Therapeutics plc Charts reveal critical insights by breaking down performance into different periods from short-term swings to long-term trends. Allergy Therapeutics plc stock shows -4.35% 1-day change, indicating low volatility, while its 5-day change of -14.06% suggests a broader trend. Over a 1-month period, a -15.38% drop could signal a pullback, whereas a 3-month decline of -25.27% may reflect broader market sentiment. Longer timeframes help assess sustained performance. A 6-month change of 29.41% and a YTD drop of -19.12% might concern investors, but a 1-year gain of 92.98% and a 3-year drop of -99.77% could indicate resilience. The 5-year surge of -99.50% highlights weak historical growth, while the all-time return of 274.15% underscores long-term potential. Whether tracking intraday moves or multi-year trends, analyzing these metrics helps traders and investors make data-driven decisions.

Frequently Asked Questions

;